Security record · archived quarter
ZURA
Zura Bio Limited · Healthcare · Biotechnology
9Tracked holders
0Δ holders
5.19MShares held
$12.99MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +15.8% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 44 | +6 | 19.12M | $111.66M | +15 | −9 |
| Q1 2026 | 39 | +4 | 16.55M | $97.28M | +6 | −2 |
| Q4 2025 | 35 | -1 | 16.01M | $83.89M | n/a | −1 |
| Q3 2025 | 16 | +3 | 16.65M | $72.09M | +3 | n/a |
| Q2 2025 | 10 | -1 | 5.96M | $6.26M | n/a | −1 |
| Q1 2025 | 8 | -1 | 4.76M | $6.14M | +1 | −2 |
| Q4 2024 | 9 | 0 | 5.19M | $12.99M | +1 | −1 |
| Q3 2024 | 8 | +2 | 3.98M | $16.15M | +2 | n/a |
| Q2 2024 | 6 | n/a | 3.73M | $12.85M | n/a | n/a |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 2.41M | 0.0% | $6.03M | 0.0% | Held | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 955.43K | +4.7% | $2.39M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 701.28K | +1499.0% | $1.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 509.60K | n/a | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Adage Capital Partners ✦ | 300.00K | New | $750,000 | 0.0% | New | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 129.11K | +102.1% | $322,785 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 106.63K | -39.8% | $266,565 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 57.78K | -82.8% | $144,448 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 20.83K | +35.9% | $53,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $750,000 | 0.0% |
Exited
| AQR Capital Management | $58,878 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 92 holders, 61.32M shares, $364.31M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API